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While it is clear that a single hematopoietic stem
cell (HSC) is capable of giving rise to all other hema-
topoietic cell types, the differentiation paths beyond
HSC remain controversial. Contradictory reports
on the lineage potential of progenitor populations
have questioned their physiological contribution of
progenitor populations to multilineage differentia-
tion. Here, we established a lineage tracing mouse
model that enabled direct assessment of differentia-
tion pathways in vivo. We provide definitive evidence
that differentiation into all hematopoietic lineages,
including megakaryocyte/erythroid cell types, in-
volves Flk2-expressing non-self-renewing progeni-
tors. A Flk2+ stage was used during steady-state
hematopoiesis, after irradiation-induced stress and
upon HSC transplantation. In contrast, HSC origin
andmaintenance do not include a Flk2+ stage. These
data demonstrate that HSC specification and main-
tenance are Flk2 independent, and that hematopoi-
etic lineage separation occurs downstream of Flk2
upregulation.
INTRODUCTION
A core goal of stem cell biology is to understand howmultipotent
cells commit to specific cell fates. Comprehensive knowledge of
differentiation pathways and the molecular regulation of fate
decisions is necessary to efficiently guide uncommitted cells
into specific fates; such directed differentiation serves as the
basis for ESC differentiation into cell types of therapeutic value.
Differentiation pathways must also be understood to enable
rational drug design. Indeed, the concept of therapeutic target-
ing of cancer stem cells relies on understanding the cellular
events underlying oncogenesis and distinguishing those from
normal cell differentiation.
The well-studied hematopoietic system is at the forefront of
lineage mapping during both normal and abnormal cell develop-
ment. HSCs have been isolated to high purity and single-cell
transplantation has demonstrated that clonal HSCs are capable64 Cell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc.of life-long reconstitution of all blood cell types (Ema et al., 2005;
Kiel et al., 2005; Morita et al., 2010; Osawa et al., 1996; Wagers
et al., 2002; reviewed in Hock, 2010). Although the concept of
hierarchical hematopoietic differentiation from HSCs into
lineage-restricted progenitor cells (Akashi et al., 2000; Kondo
et al., 1997; Nakorn et al., 2003) is widely accepted, several
recent reports have questioned the accuracy of schematic
lineage maps (e.g., Figure 1A) (reviewed in Akashi, 2005, 2009;
Hock and Orkin, 2005; Luc et al., 2008b). Recent questions
have focused on when the initial lineage decision is made, which
lineage (or lineages) is specified or lost first, and whether differ-
entiation follows linear, obligatory paths, or whether there are
alternative pathways to a specific fate. In particular, pathways
of megakaryocyte and erythroid (MegE) development from
HSCs are controversial (Adolfsson et al., 2005; Forsberg et al.,
2006; Lai and Kondo, 2006; Lai et al., 2005; Nutt et al., 2005). Up-
regulation of Flk2 (Flt3), a tyrosine kinase receptor differentially
expressed on functionally distinct hematopoietic subpopula-
tions (Adolfsson et al., 2001; Christensen and Weissman, 2001;
D’Amico and Wu, 2003; Karsunky et al., 2003, 2008) (Figure 1A),
marks the loss of the self-renewal potential of hematopoietic
cells; thus, HSCs reside within the Flk2– c-kit+Lin–Sca1+ (KLS)
fraction of adult bonemarrow (BM) (Adolfsson et al., 2001; Chris-
tensen and Weissman, 2001). Flk2 itself and Flk2+ lymphoid-
committed populations have been shown to promote lymphoid
development, as genetic deletion of Flk2 leads to decreased
numbers of B lineage cells (Mackarehtschian et al., 1995). In
contrast, myeloid-committed progenitors do not express Flk2,
and Flk2-deficient mice have normal numbers of mature myeloid
cells. Flk2 expression on KLS cells has also been reported to
correlate with loss of MegE potential and prime uncommitted
cells for a lymphoid fate (Adolfsson et al., 2005). Extensive func-
tional and molecular characterizations of Flk2+ KLS cells have
demonstrated low MegE readout in vitro and increased expres-
sion of transcripts associated with lymphoid development, with
retention of robust granulocyte/macrophage (GM) potential
(Adolfsson et al., 2005; Luc et al., 2008a; Sitnicka et al., 2007).
However, at least some cells within the Flk2+ KLS fraction retain
MegE potential in vivo (Forsberg et al., 2006; Lai and Kondo,
2006; Luc et al., 2008a). Quantitative assessment of the lineage
potential of multiple cell populations in parallel showed that
MegE contribution from Flk2+ multipotent progenitors (MPPF)
was more robust than that from progenitor populations with
undisputed MegE potential (Forsberg et al., 2006). These
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are capable of giving rise toMegE cells under conditions of acute
need, but are normally dedicated to providing lymphoid cells.
Transplantation assays, in combination with molecular charac-
terization, have been unable to provide conclusive evidence for
this model. Since no reports have ascertained the relative contri-
bution of possible alternative pathways, the physiological rele-
vance of different progenitor populations in development of
distinct lineages remains uncertain (Figure 1A). Here, we have
established a lineage tracingmodel that enabled us to determine
the contribution of non-self-renewing MPPs, marked by Flk2
expression, to the distinct hematopoietic lineages during both
steady-state and stress hematopoiesis in vivo.
RESULTS
Establishment of a Dual-Color Reporter Mouse Model
To determine which hematopoietic lineages develop through
a Flk2+ stage, we generated ‘‘FlkSwitch’’ mice by crossing
mice expressing Cre recombinase under the control of Flk2
regulatory elements (‘‘Flk2-Cre’’ BAC transgenic mice) (Benz
et al., 2008) to mice containing a dual-color fluorescent reporter
in the Rosa26 locus (‘‘mT/mG’’ mice) (Muzumdar et al., 2007)
(Figure 1B). We expected that all cells in the resulting FlkSwitch
mice would express the red-fluorescing protein Tomato (Tom),
with the exception of cells expressing Cre because Cre-medi-
ated excision of Tom would result in induction of GFP expres-
sion. Importantly, because Tom excision is an irreversible
genetic event, all progeny of Cre-expressing cells would also
express GFP regardless of whether these progeny themselves
express Cre. Flow cytometry analysis revealed that >99% of
platelets and nucleated BM and PB (peripheral blood) cells in
both mT/mG and FlkSwitch mice express either the Tom or
GFP reporter gene.
We envisioned two main experimental outcomes: if Flk2+
progenitors are significant physiological contributors to erythro-
and megakaryopoiesis in vivo, MegE cells would inherit the
floxed, GFP-expressing reporter allele and be GFP+, as indi-
cated in the left schematic of Figure 1A. Alternatively, Flk2+
progenitors may be capable of providing MegE cells when trans-
planted into irradiated animals due to the acute requirement for
erythrocytes and platelets, but may not normally contribute to
MegE generation. In this model, Flk2– multipotent progenitors
or HSCs would give rise to common myeloid progenitors
(CMPs) or megakaryocyte/erythroid progenitors (MEPs) without
differentiation through a Flk2+ stage, and mature MegE and/or
GMs, and their progenitors, would remain Tom+ (Figure 1A, right
model).
All Hematopoietic Cell Types except HSCs Switch
from Tom to GFP Expression
To distinguish between these possibilities, we analyzed the color
of distinct cell types in FlkSwitch mice by multicolor flow cytom-
etry. HSCs were defined as Flk2– BM cells that were also c-kit+,
Lin–, Sca1+, CD150+, and CD48– (Figure S1A available online).
This population contains all Flk2– KLS cells and is heteroge-
neous for CD34, and thus includes cells that have been referred
to as ‘‘ST-HSC’’ in previous reports (Figure S1B). The entire
remaining KLS fraction was divided into ST-HSCF and MPPFbased on the level of Flk2 expression (intermediate for ST-
HSCF and high for MPPF) and differential expression of CD150
and CD48 (Figure S1A).
Importantly, HSCs expressed the Tom transgene, but not GFP
(Figure 1C, Table 1), demonstrating that excision of GFP does
not occur aberrantly in Flk2– populations. Lack of recombination
in HSCs also demonstrated that all developmental precursors of
HSCs are Flk2–. Analysis of ST-HSCF and MPPF revealed
a dramatic color change from Tom to GFP as Flk2 and Cre
expression was turned on (Figure 1C, Figure S2A, Table 1).
This striking color switch (up to 97%) from Flk2– HSCs to
Flk2+ MPPs established that the reporter model operated as
expected.
Strikingly, all cell populations of the myeloid lineage, including
CMPs, granulocyte/macrophage progenitors (GMPs), MEPs,
erythroid progenitors (EPs), and platelets (Plts), exhibited the
same GFP percentage as MPPF (Figures 1C–1E, Figure S2A,
Table 1). Subfractionation of myeloid populations using alterna-
tive markers (Pronk et al., 2007) revealed similar results (Fig-
ure S2B). The almost complete color switch (up to 98%) in
erythroid cells and Plts was particularly surprising given the
uncertainty of Flk2+ cell contribution to MegE lineages. Even in
mice with low floxing efficiency in Flk2+ populations (mice #1-5
in Table 1; Figure S2A), the GFP+ percentage in all myeloid
and erythroid cell populations closely followed the GFP+
percentage in MPPF (Figures 1D and 1E, Table 1).
To determine whether myeloid cells switch color due to differ-
entiation through a Flk2+ progenitor stage or due to aberrant
recombination, we investigated Cre expression and activity.
Cre mRNA was readily detectable in MPPF, but not in HSCs or
myeloid progenitors, demonstrating a Flk2-dependent Cre
expression pattern (Figure 2A). We then tested whether myeloid
progenitors exhibit Cre recombinase activity. Unfloxed (Tom+)
and floxed (GFP+) CMPs and MPPF were isolated from
FlkSwitch mice and differentiated in vitro or transplanted into
recipient mice. As expected, all progeny of GFP+ CMPs and
MPPF in vitro and in the PB and spleen of recipient mice were
GFP+ (Figures 2B–2D). In contrast, Tom+ MPPF gave rise to
both Tom+ and GFP+ progeny in all three assays (Figures 2B–
2D). Importantly, we never detected GFP+ progeny from Tom+
CMPs, as they exclusively gave rise to Tom+ progeny in vitro
and in vivo. The lack of detectable Cre mRNA and recombinase
activity in myeloid progenitors and their progeny demonstrated
that Cre is expressed and functional in a Flk2-dependent
pattern, and support a model wherein myeloid cells are derived
from Flk2-expressing progenitors.
Tom-Expressing and GFP-Expressing Cells
Are Functionally Equivalent
The highly variable floxing efficiency between different mice
(from 6% to 97% in MPPF) makes it unlikely that Tom+ and
GFP+ cells within a phenotypic fraction are fundamentally
different. Transcriptional analysis revealed a trend toward
increased levels of Flk2 and Cre mRNA in GFP+ compared to
Tom+ MPPF (Figure 3A), consistent with floxing efficiency
increasing with Flk2 levels. To directly test whether floxed and
unfloxed cells are functionally equivalent, we compared the
in vivo colony forming units spleen (CFU-S) and PB reconstitu-
tion abilities of purified Tom+ and GFP+ MPPF and CMPs. WeCell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc. 65
Figure 1. HSC Progeny Switch from Tom to GFP Expression in FlkSwitch Mice
(A) Two simplified alternative models for HSC differentiation. Cell types that are Flk2+ or derived from Flk2+ cells should express GFP, while Flk2– cells that have
no history of Flk2 expression should express Tom. (B) Strategy for the generation of FlkSwitch reporter mice. (C) Representative flow cytometer data of Tom
and GFP expression in multiple cell populations from a FlkSwitch mouse with high floxing efficiency (mouse number 8 in Table 1). (D) Fold difference in percent
GFP+ cells compared to MPPF in high-efficiency floxers (mice numbers 6–14 in Table 1; n = 9), and (E) low-efficiency floxers (mice numbers 1–5 in Table 1; n = 5).
*p < 0.01, **p < 0.001 by Wilcoxon Signed Rank test, calculated using the raw GFP percentage (Table 1). GFP percentages in HSCs and ST-HSCF were
significantly different from all other hematopoietic cell types. HSC, hematopoietic stem cells; ST-HSCF, short-term hematopoietic stem cells; MPPF, multipotent
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Table 1. Percent GFP in Hematopoietic Populations from FlkSwitch Mice
Mouse # HSC ST-HSCF MPPF CMP GMP MEP GM EP Plt CLP** B cell** T cell*
1 0 1 6 7 7 7 10 7 6 15 38 23
2 0 2 7 6 6 9 10 6 8 14 32 20
3 0 5 12 12 12 13 11 12 13 27 47 23
4 0 5 12 10 12 12 13 12 13 27 50 28
5 0 4 20 18 20 19 21 18 21 25 44 19
6 0 63 89 91 90 89 86 86 92 91 97 94
7 0 51 90 88 89 91 90 88 93 91 99 92
8 0 44 90 88 89 90 89 90 92 97 98 96
9 0 61 92 92 92 93 92 92 91 96 100 95
10 0 37 94 94 94 94 93 93 93 98 100 97
11 0 68 95 94 93 92 92 93 86 98 99 94
12 0 45 95 95 95 97 94 97 98 100 100 96
13 0 74 96 94 94 93 94 94 93 99 100 94
14 0 60 97 98 99 99 98 98 96 99 100 100
The differences between MPPF versus CLPs, B cells, and T cells were significant (**p < 0.001, **p < 0.001, and *p < 0.01, respectively), by Wilcoxon
Signed Rank Test. HSCs and ST-HSCF were also significantly different from MPPF and all other populations. No other comparisons to MPPF were
significantly different. Abbreviations are as in Figure 1. See also Figure S2.
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tial (Figures 3B and 3C) or CFU-S frequencies (Figures 3D and
3E) between Tom+ and GFP+ MPPF or between Tom+ and
GFP+ CMPs. We then analyzed the relative number of Cre trans-
genes between different mice by performing qPCR of genomic
DNA. Indeed, mice with low floxing efficiency had fewer copies
of the Flk2-Cre construct compared to high-floxing mice (Fig-
ure 3F). These data are consistent with the increase in floxing
efficiency observed upon selective backcrossing of FlkSwitch
mice. Collectively, these results led us to conclude that Tom+
and GFP+ cells within a phenotypic population are functionally
equivalent and that the differential floxing efficiency between
different mice is due to varying copy numbers of the Cre
transgene.
Analysis of Low-Efficiency Floxers Revealed Increased
Reporter Switching in Lymphoid, but Not Myeloid, Cells
In contrast to MegE development, there is considerable agree-
ment that MPPF are capable of both GM and lymphoid differen-
tiation (Adolfsson et al., 2001, 2005; Christensen andWeissman,
2001; Forsberg et al., 2006; Lai and Kondo, 2006; Lai et al.,
2005). In addition, several populations with lymphoid-restricted
potential, including common lymphoid progenitors (CLPs) and
fractions of ProB and ProT cells, express Flk2 (Karsunky et al.,
2003, 2008). It is therefore less surprising that cells of the
lymphoid lineage also switch to GFP expression in the FlkSwitch
mice (Figure 1C, Figure S1, Table 1). Indeed, statistical analysis
revealed that Tom excision increased during lymphoid develop-
ment (Table 1). Because it is not possible to substantially
increase the percentage of floxed cells when it’s already very
high in MPPF, this effect is most apparent in low-efficiencyprogenitors; CMP, common myeloid progenitors, GMP, granulocyte/macrophag
macrophage cells; EP, erythroid progenitors; RBC, red blood cells; Plt, platelets;
standard error of the mean (SEM). See also Figure S1.floxers (mice numbers 1–5 in Table 1; Figure 1E). The increased
reporter switch is likely a result of sustained Cre expression
during development through additional Flk2+ progenitor stages,
such as CLP, ProB, and ProT cells (Karsunky et al., 2003, 2008).
In contrast, myeloid cells did not display a detectable increase in
percent GFP+ cells compared to MPPF, consistent with Flk2+
cells not contributing significantly to myelopoiesis beyond the
MPPF stage.
Hematopoietic Differentiation Occurs through a Flk2+
Stage under Stress Conditions
To test whether alternative differentiation pathways can be used
when there is an acute requirement for MegE cells, we analyzed
the color composition of hematopoietic cells under stress condi-
tions. First, we subjected FlkSwitch mice to sublethal irradiation
and analyzed the color composition of mature cells in the PB
over time. Intriguingly, the percentage of GFP+ Plts, EPs, and
GMs, but not B and T cells, decreased for the first 3 weeks after
irradiation (Figure 4A). Three weeks postirradiation, the
percentage of GFP+ myeloid cells started to rebound. A second
sublethal dose of irradiation at week 5 elicited a similar
response, with GFP percentages in Plts, EPs, and GM cells
decreasing for 3 weeks to then increase over the next several
weeks (Figure 4A). The magnitude of the changes in GFP
percentages was similar for Plts, EPs, and GM cells, whereas
neither B nor T cells displayed significant changes in the percent
of GFP+ cells.
The myeloid-specific decrease in GFP frequencies upon
irradiation suggested that a proportion of the myeloid cells
may be derived directly from Flk2– progenitors, ‘‘skipping’’
the Flk2+ intermediate stage used during steady-statee progenitors; MEP, megakaryocyte/erythroid progenitors; GM, granulocyte/
CLP, common lymphoid progenitors; B, B cells; T, T cells. Error bars indicate
Cell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc. 67
AB
C
D
Figure 2. Lack of Cre Expression and Activity inMyeloid Progenitors
at Steady-State and upon In Vivo and In Vitro Differentiation
(A) Quantitative RT-PCR analyses of Cre recombinase mRNA levels in Flk2+
(MPPF) and Flk2– (HSC; myeloid progenitors [MyPro; Lin–c-kit+Sca1– cells]
and erythroid progenitors [EP; Ter119–Mac1–Gr1–B220–CD3–CD71+]) cell
populations from FlkSwitch mice revealed that only MPPF express Cre. Bar
graph indicates the relative levels of Cre mRNA in cell populations sorted from
individual (gray bar) or multiple (white bar; n = 3) FlkSwitch mice. b-actin was
used as a positive control for all populations. Error bars indicate SEM.
(B–D) Tom+ CMPs remain unfloxed during myeloid development. (B) Flow
cytometry analysis of MPPF and CMP progeny after 10 days of in vitro methyl-
cellulose culture (n = 6 in two independent experiments). (C) Tom and GFP
analysis of donor-derived nucleated cells (total), GMs, B cells, T cells, and Plts in
PB of sublethally irradiatedmice transplantedwith Tom+ orGFP+MPPF (800 per
mouse)orCMPs(10,000permouse) (n=5–7 intwo independentexperiments). (D)
EP readout inspleensof lethally irradiatedmice11and9daysposttransplantation
of Tom+ or GFP+ MPPF or CMP (n = 10 in two independent experiments).
Cell Stem Cell
Stem Cell Differentiation Paths
68 Cell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc.hematopoiesis. Alternatively, overall floxing efficiency could be
decreased in Flk2+ progenitors. To distinguish between these
possibilities, we analyzed the color composition of stem and
progenitor cells in the BM at 2 weeks (one sublethal dose) and
19 weeks (two sublethal doses) postirradiation. As shown in
Figures 4C and 4D, the percentage of GFP+ MPPF was the
same as that of mature myeloid cells, and of all myeloid progen-
itor populations. These data are inconsistent with a bypass
pathway and instead support an irradiation-induced decrease
in floxing efficiency. Indeed, comparing GFP percentages of
cells from unirradiated mice (Figure 4B) to cells from irradiated
mice (Figures 4C and 4D) with similar floxing efficiencies in the
PB prior to irradiation (95%) indicated that irradiation caused
a reduction in floxing efficiency in MPPF. This effect was not
detectable in B and T cells, presumably due to the multiple
Flk2+ progenitor stages during lymphoid differentiation.
HSCs Differentiate through a Flk2+ Stage upon
Transplantation
We then tested differentiation pathways upon transplantation.
HSCs isolated from high-floxing (95% GFP+ myeloid PB cells)
FlkSwitch mice were transplanted into sublethally irradiated
wild-type mice, followed by PB analysis of donor-derived
progeny. Figure 5A shows the robust, long-term reconstitution
of nucleated blood cells and Plts in recipient mice. Analysis of
the color composition of PB progeny revealed that the percent-
ages of GFP+ Plts, GM, and B cells increased with time after
transplantation (Figure 5B). B cells quickly reached >90%
GFP+ cells, whereas the increase in the GFP+ percentage of
Plts and GM cells plateaued at50% 8 weeks after transplanta-
tion. Robust T cell readout was first detected at 5 weeks post-
transplantation, with T cells displaying high GFP percentages
throughout the time course. Analysis of the BM cell populations
from the same mice 16–18 weeks after transplantation revealed
that the GFP percentages were similar inMPPF, myeloid progen-
itors, Plts, and mature GM cells (Figure 5C). These results are
similar to those from the sublethal irradiation experiments and
prompted us to conclude that myeloid cells, including MegE
cells, are derived through a Flk2+ progenitor stage even under
hematopoietic stress conditions.
DISCUSSION
All Hematopoietic Cells Differentiate
through a Flk2+ Stage
Our data clearly demonstrate that upregulation of Flk2 is a shared
feature of HSC differentiation into all hematopoietic cell types.
Thus, the FlkSwitch lineage tracing model definitively rules out
differentiation of HSCs directly into Flk2– myeloid-committed
progenitors or mature myeloid cells. The model also provides
definitive evidence that HSC specification and maintenance do
not involve Flk2+ developmental stages. During steady-state,
irradiation-induced stress, and upon HSC transplantation, all
myeloid subpopulations displayed reporter recombination, with
up to 98% of Plts and EPs being GFP labeled. Although we did
not observe a 100% color switch in myeloid populations, we
showed that this is the result of imperfect floxing efficiency as
opposed to bypass of the Flk2+ stage (Figure 1, Figure 2, Fig-
ure 4, and Figure 5). MPPF, by definition, do not bypass the
AD E F
B C Figure 3. Tom+ MPPF and CMPs Exhibit
Similar In Vivo Reconstitution Potential to
That of Their GFP+ Counterparts
(A) Quantitative RT-PCR analyses of Cre re-
combinase and Flk2 mRNA levels in Tom+ and
GFP+ MPPF isolated from individual FlkSwitch
mice (n = 4).
(B–E) Tom+ and GFP+ MPPF (B and D) and CMPs
(C and E) give rise to similar numbers of Plts, GMs,
B and T cells (B and C), and CFU-S (D and E).
Purified Tom+ and GFP+ MPPF (800 per mouse,
n = 7 and 8) or Tom+ and GFP+ CMPs (10,000 per
recipient, n = 5) were transplanted into sublethally
irradiated hosts and the PB readout was analyzed
weekly for 30 days posttransplantation (B and C).
For CFU-S analysis, 300 Tom+ or GFP+ MPPF
(n = 10) or 200 Tom+ and GFP+ CMPs (n = 10 in
two independent experiments) per recipient were
transplanted into lethally irradiated hosts. CFU-S
were enumerated 11 or 9 days posttransplantation
(D and E). (F) The percentage of GFP+ cells in PB
myeloid cells correlates with Cre transgene copy
number. Error bars in (A)–(E) indicate SEM; no
comparisons were statistically significantly
different.
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favorable to ‘‘escape’’ the Flk2+ stage during myeloid differenti-
ation, a proportion of myeloid progeny would be generated
through the bypass pathway and remain Tom+. This scenario
may be more readily detectable in low-efficiency floxers and in
mice under hematopoietic stress, but was not observed under
any condition examined. Furthermore, we ruled out Cre misex-
pression or activity as significant contributors to reporter switch-
ing in myeloid cells (Figure 2). This allowed us to conclude that all
hematopoietic cells, including cells of the MegE lineage, are
derived from HSCs through a Flk2+ progenitor. Bo¨iers et al.
(2010) recently made similar conclusions for granulocyte differ-
entiation when analyzing granulocytic and MegE development;
however, they did not report their findings on erythroid cell or
platelet origins.
Robustly Flk2+ Cells Are the Likely Immediate
Progenitors of Myeloid-Committed Cells
Our observation that all myeloid populations exhibit the
same floxing efficiency as MPPF in FlkSwitch mice under
both steady-state and dynamic conditions, and the lack of iden-
tification of a downstream Flk2+ cell type with MegE capability,
points to MPPF as the likely intermediate Flk2+ cell population
(Figure 1A, left). Importantly, multipotent progenitors with previ-
ously demonstrated MegE potential (Flk2–CD34+ KLS cells) and
our ST-HSCF (here defined by intermediate Flk2 cell surface
expression) lack (Figure S1B) or display significantly lower
(Figures 1C–1E, Figures 4B–4D, Figure 5C, Table 1) floxing
efficiency compared to myeloid progenitors and mature cells.
Because CMPs lacked any detectable recombinase expression
or activity, we find it unlikely that these ST-HSC populations are
the immediate progenitors of myeloid-committed cells. In
contrast, MPPF and all myeloid populations exhibited the same
proportion of floxed cells in every mouse examined (Figures
1C–1E, Figures 4B–4D, Figure 5C, Table 1). This concordance
in GFP percentages between MPPF and myeloid populationswas remarkably conserved even during the highly dynamic con-
ditions of hematopoietic stress (Figure 4 and Figure 5). Known
marker heterogeneity within Flk2+ populations (as well as
HSCs; see below) raises the possibility that lineage biases occur
during or prior to Flk2 upregulation. Thus, while it is possible that
the cells within the Flk2+ fraction that give rise to MegE lineages
are different from the cells that give rise to lymphoid cells, loss of
MegE ability before the onset of Flk2 expression (Figure 1A, right)
is incompatiblewith thedatawepresent here. Instead, our results
support a model wherein all hematopoietic lineages develop
through a robustly Flk2+ intermediate.
Comparison of Steady-State Hematopoietic
Differentiation to Pathways in Transplantation Models
Given the relatively poor MegE readout in vitro and low CFU-S
frequency in vivo from Flk2+ progenitors (Adolfsson et al.,
2005; Forsberg et al., 2006), one might have expected that at
least a fraction of MegE cells would be derived from a Flk2-inde-
pendent pathway. In contrast, our data revealed that all MegE
cells are derived via a Flk2+ stage. Flk2 clearly plays a role in
lymphoid development (Mackarehtschian et al., 1995). However,
it is important to distinguish between the function of Flk2 itself
and the role of cell populations defined by Flk2 expression.
Our data show that upregulation of Flk2, and other lymphoid-
characteristic genes, does not exclude MegE development
in vivo, and suggest that in vitro assays may underestimate
MegE potential.
Hematopoietic differentiation pathways have been modeled
primarily on hematopoietic reconstitution upon transplantation,
and we therefore considered the possibility that steady-state
hematopoiesis may differ from transplantation hematopoiesis.
The FlkSwitch model is uniquely suited to assess differences
between unmanipulated, steady-state hematopoiesis and differ-
entiation that occurs under high-stress conditions. However, our
lineage tracing results showed that hematopoietic pathways are
similar during steady-state and transplantation, and consistentCell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc. 69
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Figure 4. Hematopoietic Differentiation
under Irradiation-Induced Stress Prog-
resses through a Flk2+ Stage
(A) Analysis of PB cells of FlkSwitch mice before
and after irradiation-induced stress revealed
a myeloid-specific decrease in the percentage of
cells expressing the GFP reporter gene, with
a concomitant increase in the percentage of cells
expressing Tom. GFP percentages in Plts (black
line), GMs, and B and T cells (not shown) remain
unchanged over time in unirradiated mice.
(B–D) Ratio of GFP to Tom expression in BM cell
populations without irradiation (B), 2 weeks after
one sublethal irradiation dose (C), and 19 weeks
after two sublethal doses administered at weeks
0 and 5 (D), demonstrating that the decrease in
MPPF floxing efficiency is reflected in myeloid
populations. The black dotted line indicates
average GFP percentages of myeloid PB cells of
the same mice prior to irradiation. Error bars
indicate SEM. p values were determined using
a paired two-tailed t test. *p < 0.05, **p < 0.005,
***p < 0.0005, ****p < 0.00005. GFP percentages in
HSCs and ST-HSCF were significantly different
from all other hematopoietic cell types (B–D).
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plantation assays (Figure 1A, left). The increased floxing effi-
ciency observed in the lymphoid lineage with GFP percentages
increasing from MPPF to CLP and again from CLP to B and
T cells (e.g., Figure 1E) is consistent with MPPF giving rise to B
and T cells via a CLP intermediate. In contrast to lymphoid cells,
GMs did not display a detectable increase in percent GFP+ cells
compared to MPPF, possibly indicating that any physiological
contribution of Flk2+ myeloid progenitors to GMs (Bo¨iers et al.,
2010; Nutt et al., 2005) is relatively low compared to the contribu-
tion by Flk2– CMPs. In addition, neither high- nor low-efficiency
floxers showed an increase in GFP percentages in CMPs, GMPs,
MEPs, EP, or Plts compared to MPPF, consistent with Flk2+
cells not contributing significantly to those lineages beyond the
MPPF stage. These observations justify a focus exclusively on
Flk2– cell types when further investigating myeloid-committed
progenitor cells. Intriguingly, the dynamics and magnitude of
the changes in GFP percentages were strikingly similar for Plts,
EPs, and GM cells during irradiation-induced stress and
recovery. These data are consistent with the existence of
a shared myeloid progenitor cell, as concluded upon the identi-
fication of CMPs (Akashi et al., 2000). By establishing the phys-
iological contribution of specific progenitors to distinct hemato-
poietic lineages, our lineage tracing results eliminate several
question marks from pathway models based on transplantation
assays.
HSC Specification and Maintenance Do Not Include
Flk2+ Stages
Our data also provide important clues on the developmental
origin and maintenance of HSCs themselves. First, because
adult HSCs are Tom+ in FlkSwitch mice, all developmental
precursors to BM HSCs must be Flk2–. Second, because70 Cell Stem Cell 9, 64–73, July 8, 2011 ª2011 Elsevier Inc.HSCs remain Tom+ in adulthood, we conclude that dedifferenti-
ation of Flk2+ progenitor cells back to the stem cell stage is
extremely low or nonexistent. The recently reported heteroge-
neity of cells that fits the classical definition of HSCs (reviewed
by Hock, 2010; Schroeder, 2010) has put into question the hier-
archy of different ‘‘HSC’’ populations. Importantly, previous
studies have shown that HSCs separated by cell cycle status
show differential reconstitution ability (Fleming et al., 1993;
Passegue´ et al., 2005). Because these cells are arguably HSCs
even though their reconstitution ability (and likely at least some
markers) is altered by cell cycling, some degree of heterogeneity
must be allowed. This transient difference in reconstitution ability
also reminds us that transplantation models are dependent on
the engraftability of cells at any given time, and that the behavior
of transplanted cells may differ from unmanipulated resident
cells with the same marker phenotype. It is not yet clear whether
HSCs cycle back and forth between different marker pheno-
types. Here we show that such possible HSC differentiation/
dedifferentiation does not include cells beyond the Flk2+ stage,
establishing a clear hierarchy between HSCs and non-self-
renewing progenitors.
Stem Cell Fate Decisions
Do stem cells, themselves, make fate decisions? While we
addressed this question in a specific system (hematopoiesis)
with a specific tool (Flk2-driven Cre expression), the concept of
when cell fate decisions are made is relevant for all stem cell
types and developmental systems. Even in the intensely investi-
gated hematopoietic system, it is clear from the many proposed
versions of hematopoietic lineage maps (Akashi, 2009; Ceredig
et al., 2009; Hock and Orkin, 2005; Laiosa et al., 2006; Luc
et al., 2008b) that fundamentally important questions remain
unresolved. Our results clearly demonstrate that ‘‘multipotent’’
AB
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Figure 5. HSCs Differentiate into All Lineages through a Flk2+ Stage
upon Transplantation
(A) Donor chimerism in recipient mice transplanted with 100 HSCs from
FlkSwitch mice demonstrates robust long-term engraftment of nucleated
(GMs, B cells, and T cells) PB cells, as well as Plts.
(B) GFP percentages of donor-derived B cells, Plts, and GMs increase for the
first few weeks after transplantation and then remain stable.
(C) BM analysis of recipient mice >16 weeks posttransplantation revealed that
MPPF displayed similar GFP percentages as myeloid progenitors, Plts, and
GMs. The black dotted line indicates the GFP percentage of MPPF of the same
mice prior to transplantation. (n = 7 in two independent experiments.) Error
bars indicate SEM. p values were determined using a two-tailed paired t test.
Cell Stem Cell
Stem Cell Differentiation Pathsprogenitors are not only capable of providing all hematopoietic
lineages upon transplantation under acute stress conditions,
but that they do contribute to all lineages under both steady-
state and stress conditions in vivo. This definitive demonstration
of the physiological significance of the multilineage capability of
a progenitor subpopulation justifies further efforts into targeting
MPP, and analogous populations in other stem cell systems, to
enable efficient manipulation of cell fate decisions.
EXPERIMENTAL PROCEDURES
Mice
Mice were maintained in the UCSC vivarium according to IACUC approved
protocols. mT/mG reporter mice containing a loxP-flanked Tom transgene
followed by enhanced GFP in the Rosa26 locus, and Flk2-Cre mice generated
by Cre recombinase expression from a Flk2 BAC transgene, were described
previously (Benz et al., 2008; Muzumdar et al., 2007). FlkSwitch mice were
generated by breeding mT/mG reporter mice and Flk2-Cre mice. Early gener-
ations displayed low floxing efficiency, while subsequent backcrossed gener-
ations displayed increasing floxing efficiencies nearing 100%.
Cell Isolation and Analysis
BM and PB cells were isolated and processed as described previously
(Forsberg et al., 2005, 2006; Smith-Berdan et al., 2011) using a four-laser
FACSAria or LSRII (BD Biosciences, San Jose, CA). Flowjo Software
(Ashland, OR) was used for data analysis and display. Cell populations
were defined by the following cell surface phenotypes: HSC (Lin–Sca1+c-kit+
CD48–Slamf1+Flk2–), ST-HSCF (Lin–Sca1+ c-kit +Flk2intermediate), MPPF
(Lin–Sca1+ c-kit+CD48+Slamf1–Flk2+), CMP (Lin–Flk2–Sca1– c-kit+FcgRmid
CD34mid), GMP (Lin–Flk2–Sca1– c-kit+FcgRhiCD34hi), MEP (Lin–Flk2–Sca1–
c-kit+FcgRloCD34lo), CLP (Lin–Sca1mid c-kitmidFlk2+IL7Ra+), GM (Ter119–
Mac1+Gr1+CD3–B220–), EP (Mac1–Gr1–CD3–B220–Ter119+CD71+), Plts
(FSCloTer119–CD61+), B cell (Ter119–Mac1–Gr1–CD3–B220+), and T cell
(Ter119–Mac1–Gr1–CD3+B220–). The lineage cocktail consisted of CD3,
CD4, CD5, CD8, B220, Gr1, Mac1, and Ter119.
Statistics
A Wilcoxon Signed Rank Test, appropriate for application to data with
nonparametric distribution, was used to calculate the significance of the differ-
ences in percent GFP+ cells between cell types at steady-state (Table 1).
Paired two-tailed t tests were used to calculate the significance of the differ-
ence in percent GFP+ cells between hematopoietic cell types after sublethal
irradiation and HSC transplantation. Unpaired two-tailed t tests were used
for all other statistical analyses.
Transplantation Assays
Double-sorted HSCs (100 per mouse), Tom+ or GFP+ MPPF (800 per mouse),
and CMPs (10,000 per mouse) were injected into sublethally irradiated mice
(770 rads). The BM and PB of recipients were analyzed by flow cytometry
for GFP and Tom fluorescence posttransplantation. The data in Figure 2 and
Figure 3 display PB reconstitution of Plts and GM at 9 days posttransplanta-
tion; at 9 days for total nucleated cells (CMPs only); 17 days for total nucleated
cells (MPP only); and at 30 days posttransplantation for B and T cells (MPP
only). For CFU-S analysis, Tom+ or GFP+ MPPF or CMPs were injected into
lethally irradiated mice (1036 rads). Spleens were dissected, colonies were
enumerated, and cells were analyzed by flow cytometry for GFP and Tom fluo-
rescence 9 days (CMPs) and 11 days (MPPF) posttransplantation.
Sublethal Irradiation Assays
Mice with high floxing efficiency (>95%) were given a half-lethal dose
(518 rads) of irradiation. Consecutive doses were given 5 weeks apart. PB
and BM cells were analyzed by flow cytometry for GFP and Tom fluorescence.*p < 0.005, **p < 0.001. GFP percentages in HSC and ST-HSCF were signifi-
cantly different from all other hematopoietic cell types.
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Cell Stem Cell
Stem Cell Differentiation PathsIn Vitro Culture
Twenty to fifty Tom+ or GFP+ MPPF and CMPs from FlkSwitch mice with high
floxing efficiency (>90%GFP inmaturemyeloid cells) were plated inMethocult
M3231 (Stem Cell Technologies) supplemented with SCF (25 ng/ml), IL-11
(25 ng/ml), IL-3 (10 ng/ml), Tpo (25 ng/ml), Epo (2.5 U/ml), and GM-CSF
(10 ng/ml). Cells were harvested and analyzed by flow cytometry for GFP
and Tom fluorescence after 10 days of culture.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.stem.2011.04.021.
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